Tianyikang Pharmaceutical Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14.4M

  • Investors
  • 8

Tianyikang Pharmaceutical General Information

Description

Provider of cell immunotherapy research and development focused on advancing medical research and cell technology applications to develop next-generation immunotherapy products. The company conducts cell technology development, medical research, immunotherapy product development and related laboratory research activities, serving healthcare institutions and the biotechnology sector by enabling the advancement of innovative treatment approaches for cancer and other serious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building 77-78, Lane 887, Zuchongzhi Road
  • Pudong New Area
  • Shanghai, 201210
  • China
+86 139
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 5th Floor, Building 77-78, Lane 887, Zuchongzhi Road
  • Pudong New Area
  • Shanghai, 201210
  • China
+86 139

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tianyikang Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 06-Feb-2026 $14.4M Completed Generating Revenue
To view Tianyikang Pharmaceutical’s complete valuation and funding history, request access »

Tianyikang Pharmaceutical Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Addor Capital Growth/Expansion Minority
Chengshu Capital Venture Capital Minority
Hony Capital PE/Buyout Minority
Hunt Best Capital Venture Capital Minority
Med-Fine Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Tianyikang Pharmaceutical FAQs

  • When was Tianyikang Pharmaceutical founded?

    Tianyikang Pharmaceutical was founded in 2024.

  • Where is Tianyikang Pharmaceutical headquartered?

    Tianyikang Pharmaceutical is headquartered in Shanghai, China.

  • What industry is Tianyikang Pharmaceutical in?

    Tianyikang Pharmaceutical’s primary industry is Drug Discovery.

  • Is Tianyikang Pharmaceutical a private or public company?

    Tianyikang Pharmaceutical is a Private company.

  • What is Tianyikang Pharmaceutical’s current revenue?

    The current revenue for Tianyikang Pharmaceutical is .

  • How much funding has Tianyikang Pharmaceutical raised over time?

    Tianyikang Pharmaceutical has raised $14.4M.

  • Who are Tianyikang Pharmaceutical’s investors?

    Addor Capital, Chengshu Capital, Hony Capital, Hunt Best Capital, and Med-Fine Capital are 5 of 8 investors who have invested in Tianyikang Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process